Health utility elicitation: is there still a role for direct methods?

Pharmacoeconomics. 2012 Feb 1;30(2):83-6. doi: 10.2165/11597720-000000000-00000.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Age Factors
  • Australia
  • Canada
  • Caregivers / economics
  • Caregivers / psychology
  • Cost-Benefit Analysis / methods
  • Cost-Benefit Analysis / standards
  • Economics, Pharmaceutical / standards*
  • Europe
  • Evaluation Studies as Topic
  • Health / economics*
  • Health Status
  • Humans
  • Outcome Assessment, Health Care / methods*
  • Outcome Assessment, Health Care / standards
  • Quality of Life
  • Quality-Adjusted Life Years
  • United States